Medindia

X

Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award

Friday, August 29, 2008 General News J E 4
Advertisement
MOUNTAIN VIEW, Calif., Aug. 28 The 2008 EuropeanHemodialysis Emerging Company of the Year Award is presented to RedsenseMedical in recognition of its pioneering Redsense -- a unique blood lossdetecting device. "Redsense detects the loss of blood during hemodialysis andmay save the lives of many patients".

The device consists of an alarm and a sensor patch. The sensor isconnected to the alarm using fibre optic technology that sends signalsalerting caregivers about potentially fatal blood loss. In this event, thepatch smears blood on the sensor patch that triggers the alarm.

"Redsense is a simple, user-friendly device that can be used both at homeand in dialysis centres," notes Frost & Sullivan Research Analyst SowmyaRajagopalan. "Further advances have included attaching the device to thedialysis machine, facilitating its functioning."

As the Redsense technology is patented as a generalised blood lossdetection device, it can be used for various applications other thanhemodialysis. This would essentially broaden the scope of the market andincrease revenues. Among the areas of potential application are brainsurgeries, catheterisation, angiography and angioplasty.

"With the launch of Redsense, the company has become a pioneer in thefield of blood loss detecting devices," remarks Rajagopalan. "With a growingmarket for self dialysis at home, the importance of, and demand for, Redsenseis poised to rise."

The Frost & Sullivan Award for Emerging Company of the Year is presentedto the company that has emerged as a significant participant within itsindustry. "This company is perceived to have exhibited outstanding management,superior market growth, exceptional customer service and the ability tocombine technology and successful strategic initiatives" according toRajagopalan. This company has the exceptional know-how to take advantage ofmarket changes through the execution of innovative strategies within theexisting competitive landscape.

Frost & Sullivan Best Practices Awards recognise companies in a variety ofregional and global markets for demonstrating outstanding achievement andsuperior performance in areas such as leadership, technological innovation,customer service, and strategic product development. Industry analystscompare market participants and measure performance through in-depthinterviews, analysis, and extensive secondary research in order to identifybest practices in the industry.

About Redsense Medical

After a number of incidents with venous needle dislodgement duringhemodialysis at a dialysis clinic in Sweden, the clinic's technicianscontacted a company specializing in medical technology. This cooperationbetween medical staff and engineers resulted in the start-up of RedsenseMedical in 2006. Redsense Medical has twenty-four employees and offices inSweden, US and Malaysia. More information: http://www.redsensemedical.com

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, partners with clients toaccelerate their growth. The company's TEAM Research, Growth Consulting andGrowth Team Membership(TM) empower clients to create a growth-focused culturethat generates, evaluates and implements effective growth strategies. Frost &Sullivan employs over 45 years of experience in partnering with Global 1000companies, emerging businesses and the investment community from more than 30offices on six continents. For more information about Frost & Sullivan'sGrowth Partnerships, visit http://www.frost.com.Redsense Medical Contact: Susanne Olauson - Sales and Marketing Director Phone: 0046 732 309708 Susanne.olauson@redsensemedical.com http://www.redsensemedical.com

SOURCE Frost & Sullivan
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Lenaye Lawyer, MD, FACOG, Named KePRO Medical Dire...
S
ViroPharma to Present at Three September Healthcar...